內地昨新增本土確診病例57例 廣東佔6例均在東莞市
國家衛健委最新通報,昨日(20日)新增確診病例81例。其中境外輸入病例24例(上海5例,福建5例,廣東4例,浙江3例,廣西3例,北京1例,天津1例,四川1例,陝西1例),含1例由無症狀感染者轉爲確診病例(在四川);本土病例57例(陝西43例,其中西安市42例、鹹陽市1例;浙江8例,均在紹興市;廣東6例,均在東莞市),含8例由無症狀感染者轉爲確診病例,均在陝西。無新增死亡病例。無新增疑似病例。新增無症狀感染者19例,其中境外輸入18例,本土1例(在黑龍江黑河市)。(ta/w) ~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.